Expanded Approval Broadens Use of Roche MMR Test for Immunotherapy Selection
The companion diagnostic evaluates mismatch repair deficiency, a predictive biomarker used to identify patients who may respond to PD-1-targeted therapies.
The companion diagnostic evaluates mismatch repair deficiency, a predictive biomarker used to identify patients who may respond to PD-1-targeted therapies.
ViewsML will present research on its AI-powered virtual immunohistochemistry platform at AACR 2026, highlighting biomarker detection from routine H&E slides without traditional staining.
Peer-reviewed study found 98% concordance between Techcyte's digital workflow and brightfield microscopy in routine clinical laboratory testing.
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
The MMR IHC Panel pharmDx helps identify patients eligible for immunotherapy treatment with Bristol Myers Squibb's Opdivo alone or in combination with Yervoy.
Evident has launched the IXplore IX85 SpinXL and SpinSR, two advanced spinning disk confocal microscopes that enhance live-cell imaging.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.